Not just for depression anymore
December 18, 2008Prozac is regularly prescribed to ease the emotional pain of patients who are being treated for cancer. But can this common anti-depressant help to fight cancer itself?
Dr. Dan Peer of the Department of Cell Research and Immunology at Tel Aviv University is proving that it can. A study he and his colleagues recently completed validates that Prozac (chemical name fluoxetine) dramatically enhances the effectiveness of a widely used anti-cancer drug.
"The good news is that the medical community won't have to wait — Prozac can be used for this purpose right away," says Dr. Peer, noting that doctors in the U.S. already prescribe it to treat depression in chemotherapy patients.
Fighting Drug Resistance in Colon Cancer Patients
"Prozac is a very interesting non-specific blocker of cancer resistance," says Dr. Peer, whose study focused on colon cancer and the anti-cancer drug doxorubicin.
In their laboratory experiments, the Tel Aviv University scientists led by graduate student Mirit Argov together with Prof. Rimona Margalit, found that Prozac enhanced doxorubicin's efficacy more than 1,000%. Prozac, in effect, worked to block the cancer drug from leaving the interior of the cancer cell and poisoning the healthy non-cancerous cells that surrounded it.
In animal models, a mild doxorubicin-fluoxetine treatment combination slowed down tumor progression significantly. These results suggest that pairing Prozac with chemotherapeutic drugs to curb drug resistance warrants further clinical study, says Dr. Peer.
His research was just published in Cancer Letters, and his suggestions are now listed as recommendations in the latest version of Cancer Encyclopedia.
Working Backward to Make Great Advances
"Working with a major drug developer, we have validated Prozac's potential, and now Tel Aviv University can lead a humanitarian effort to save lives around the globe," he says.
Since it is very hard to protect this patent since any clinician can prescribe Prozac, it is impossible for Tel Aviv University to commercialize its research, says Dr. Peer. Instead, he suggests that researchers join forces internationally to implement retrospective studies of all the types of cancer treatment in which Prozac was prescribed. And further clinical experiments to validate the use of Prozac with chemotherapy is also needed, he stresses.
"The next step is to take the files of chemo patients and determine whether they received Prozac for their depression," says Dr. Peer. "This will streamline the understanding in the scientific community of whether, how and for which cancer-fighting drugs Prozac can be an effective partner. It will also give us invaluable information on how to design new drugs."
Dr. Peer's Tel Aviv University lab is also developing several new drug delivery nanotechnologies to bring novel therapeutics into breast, blood, pancreatic and brain cancers. A recent technological breakthrough to reprogram immune cells involved in ulcerative colitis and Crohn's disease was reported in Science earlier this year and it is the basis of a new platform technology developed in his group.
Source: American Friends of Tel Aviv University
-
Modified Ectsasy holds promise as potent blood cancer treatment
Aug 19, 2011 |
5 / 5 (11) |
2
-
Serotonin Made in Breast Cancer Cells, Researchers Show
Nov 24, 2009 |
5 / 5 (3) |
0
-
Hunting for the Prozac gene
Oct 27, 2009 |
1 / 5 (1) |
0
-
Some antidepressants may risk breast cancer return
May 31, 2009 |
not rated yet |
0
-
Legalize it? Medical evidence on marijuana blows both ways
May 25, 2009 |
4.8 / 5 (21) |
22
-
Fast photon control brings quantum photonic technologies closer
10 hours ago |
5 / 5 (4) |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Discovery paves way for salmonella vaccine
(Medical Xpress) -- An international research team led by a University of California, Davis, immunologist has taken an important step toward an effective vaccine against salmonella, a group of increasingly antibiotic-resistant ...
12 minutes ago |
5 / 5 (2) |
0
|
First-of-its-kind stem cell study re-grows healthy heart muscle in heart attack patients
Results from a Cedars-Sinai Heart Institute clinical trial show that treating heart attack patients with an infusion of their own heart-derived cells helps damaged hearts re-grow healthy muscle.
Medicine & Health / Cardiology
18 minutes ago |
5 / 5 (1) |
0
|
Ovarian cancer arises in fallopian tube of knockout mice
(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes not the ovaries of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College ...
13 minutes ago |
not rated yet |
0
|
Smoking bans lead to less, not more, smoking at home: study
Smoking bans in public/workplaces don't drive smokers to light up more at home, suggests a study of four European countries with smoke free legislation, published online in Tobacco Control.
18 minutes ago |
not rated yet |
0
UK cases of progressive sight loss condition set to rise a third by 2020
New cases of the progressive sight loss condition, known as age-related macular degeneration, or AMD for short, are set to rise by a third in the UK over the next decade, reveals research published online in the British Jo ...
17 minutes ago |
not rated yet |
0
Scientists discover reason for Mt. Hood's non-explosive nature
(PhysOrg.com) -- For a half-million years, Mount Hood has towered over the landscape, but unlike some of its cousins in Oregons Cascade Mountains and many other volcanoes around the Pacific Rim ...
Time of year important in projections of climate change effects on ecosystems
(PhysOrg.com) -- Does it matter whether long periods of hot weather, such as last year's heat wave that gripped the U.S. Midwest, happen in June or July, August or September?
Medical school link to wide variations in pass rate for specialist exam
Wide variations in doctors' pass rates, for a professional exam that is essential for one type of specialty training, seem to be linked to the particular medical school where the student graduated, indicates research published ...
Missing dark matter located: Intergalactic space is filled with dark matter
Researchers at the University of Tokyos Institute for the Physics and Mathematics of the Universe (IPMU) and Nagoya University used large-scale computer simulations and recent observational data of gravitational ...
Plants use circadian rhythms to prepare for battle with insects
In a study of the molecular underpinnings of plants' pest resistance, Rice University biologists have shown that plants both anticipate daytime raids by hungry insects and make sophisticated preparations to ...
Sensing self and non-self: New research into immune tolerance
At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually ...